Portfolio (Quarterly)
Guide ↗
Rosalind Advisors, Inc.
· CIK 0001622627| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | MYO | MYOMO INC | Healthcare | 3,847,272.0 | $2.6M | 1.04% | — | — | $0.68 | +52.5% |
| 22 | — | TALPHERA INC | — | 3,353,916.0 | $2.5M | 1.01% | -225K | -6.3% | $0.75 | — |
| 23 | OVID | OVID THERAPEUTICS INC | Healthcare | 1,107,994.0 | $2.5M | 0.99% | NEW | — | $2.22 | +10.4% |
| 24 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 125,000.0 | $2.4M | 0.95% | NEW | — | $18.90 | +21.1% |
| 25 | — | ONKURE THERAPEUTICS INC | — | 443,763.0 | $1.8M | 0.74% | -287K | -39.2% | $4.14 | — |
| 26 | — | LIPOCINE INC | — | 221,616.0 | $1.8M | 0.71% | NEW | — | $7.99 | — |
| 27 | NRXS | NEURAXIS INC | Healthcare | 286,138.0 | $1.7M | 0.68% | — | — | $5.92 | +18.2% |
| 28 | — | AVALO THERAPEUTICS INC | — | 75,000.0 | $1.1M | 0.45% | NEW | — | $14.93 | — |
| 29 | ANNX | ANNEXON INC | Healthcare | 200,000.0 | $1.1M | 0.45% | NEW | — | $5.54 | -0.4% |
| 30 | — PUT | INVESCO QQQ TR | — | 250,000.0 | $1.1M | 0.42% | -200K | -44.4% | $4.21 | — |
| 31 | AQST | AQUESTIVE THERAPEUTICS INC | Healthcare | 250,000.0 | $1.0M | 0.42% | NEW | — | $4.15 | -1.7% |
| 32 | — PUT | SPDR S&P 500 ETF TR | — | 125,000.0 | $958K | 0.39% | -385K | -75.5% | $7.67 | — |
| 33 | — | BIOFRONTERA INC | — | 1,163,962.0 | $942K | 0.38% | +23K | +2.0% | $0.81 | — |
| 34 | KURA | KURA ONCOLOGY INC | Healthcare | 100,000.0 | $813K | 0.33% | — | — | $8.13 | +28.0% |
| 35 | — | REGENTIS BIOMATERIALS LTD | — | 251,510.0 | $768K | 0.31% | — | — | $3.05 | — |
| 36 | — PUT | VIRIDIAN THERAPEUTICS INC | — | 263,600.0 | $53K | 0.02% | NEW | — | $0.20 | — |
| 37 | — CALL | ARRIVENT BIOPHARMA INC | — | 108,900.0 | — | — | +1K | +0.9% | — | — |
| 38 | — CALL | UNIQURE NV | — | 295,800.0 | — | — | +196K | +195.8% | — | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%